Komori
EnBio Holdings,Inc (6092) · TargetReframed

Medium-Term Management Indicators Focusing on Revenue, Operating Profit and Ordinary Profit

First written in FY2019. 7 of 22 entries say "Advanced", first in FY2020-Q2. Latest entry: FY2026.

22entries
8years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2024-Q1 – FY2024-Q32019: 220192020: 320202021: 420212022: 420222023: 420232024: 220242025: 120252026: 22026
Same theme, other companies
Management indicator oversight based on revenue, operating profit and ordinary profitA theme 19 companies write about · 0 as a headwind · 19 as a tailwind

The whole theme swung hardest in 2018: 2 of 7 companies on the "Worse" side.

0 other companies' latest entry also says "Reframed".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 19 companies compared. The sentences above are computed from all 19.
Full recordFilings, disclosures and news, newest first
  1. FY2026ReframedAnnual report

    「Under the Medium-Term Management Plan 2030, the company has set management indicators including consolidated net sales, operating profit and ROE, and will work toward achieving them.」

    The company has updated its framework, replacing the previous Medium-Term Management Plan 2026 with the Medium-Term Management Plan 2030, under which consolidated net sales, operating profit and ROE are set as management indicators.
  2. 2026-05-15RaisedManagement plan

    「The targets for the final fiscal year of Medium-Term Management Plan 2030, ending March 2031, are consolidated net sales of ¥25.5 billion, double the level for the fiscal year ending March 2026, and consolidated operating income of ¥2.8 billion, 1.7 times that level.」

    The company raised its previous targets for the fiscal year ending March 2027 to new quantitative targets, including net sales of ¥25.5 billion and operating income of ¥2.8 billion for the fiscal year ending March 2031.
  3. FY2025RestatedAnnual report

    「The company formulated the Medium-Term Management Plan 2026 through the fiscal year ending March 2027, established the following two points as its basic policies, and set consolidated net sales of ¥14,640 million and operating profit of ¥1,317 million for the fiscal year ending March 2027 as management targets.」

    The company reaffirmed its management indicators emphasizing sales and operating profit, as well as its numerical targets for the fiscal year ending March 2027.
  4. FY2025-H1AdvancedAnnual report

    「As a result, net sales for the current interim consolidated accounting period were ¥5,960 million, up 8.7% year on year. Ordinary profit was ¥640 million, up 16.5%.」

    For the sales and profit metrics emphasized in the medium-term management plan, sales increased 8.7% and ordinary profit increased 16.5% during the current interim consolidated accounting period.
  5. FY2024-Q3Revenue growth, ordinary profit decline, net profit declineAnnual report

    「As a result, revenue for the nine months ended 31 December was ¥6,986.182 million, up 3.2% year on year. Ordinary profit was ¥546.223 million, down 60.1% year on year. Net profit attributable to owners of the parent was ¥345.231 million, down 59.7% year on year.」

    For the sales and profit metrics emphasized as medium-term management indicators, cumulative third-quarter sales increased, while ordinary profit and net income attributable to owners of the parent declined substantially year on year.
  6. FY2024-Q2Lower net sales, higher ordinary profit, lower net incomeAnnual report

    「As a result, revenue for the six months ended 30 September was ¥5,482.836 million, down 2.7% year on year. Ordinary profit was ¥548.945 million, down 64.1% year on year. Net profit attributable to owners of the parent was ¥321.387 million, down 67.0% year on year.」

    For the sales and profit metrics emphasized by the company, cumulative second-quarter sales declined 2.7% and ordinary profit declined 64.1%, deteriorating year on year.
  7. FY2024-Q1Revenue growth, ordinary profit decline, net profit declineAnnual report

    「As a result, net sales for the cumulative first quarter of the current consolidated fiscal year were ¥3,423 million, up 28.3% year on year. Ordinary profit was ¥345 million, down 57.4%.」

    For the sales and profit metrics emphasized by the company, sales increased during the quarter, while ordinary profit declined.
  8. FY2023AchievedAnnual report

    「The company achieved, ahead of schedule in the fiscal year ending March 2023, the target profit for the final year of its medium-term management plan.」

    The company stated that it achieved, ahead of schedule in the fiscal year ending March 2023, the target profit for the final year of its previous medium-term management plan.
  9. FY2023-Q3Lower revenue and higher ordinary incomeAnnual report

    「As a result, net sales for the cumulative third quarter of the current consolidated fiscal year were ¥6,772 million, down 7.7% year on year. On the profit side, demand remained strong not only for housing but also for non-residential properties, including business sites for general corporations. In the brownfield redevelopment business, selling prices increased, while costs were reduced with the exit strategy in mind at the time of sale, resulting in a substantial improvement in profit margins. Consequently, ordinary profit was ¥1,368 million, up 29.5%.」

    For the sales and profit metrics emphasized by the company, sales declined year on year, while ordinary profit increased 29.5% on the back of higher selling prices and cost reductions.
  10. FY2023-Q2AdvancedAnnual report

    「As a result, net sales for the cumulative second quarter of the current consolidated fiscal year were ¥5,637 million, up 31.0% year on year. Ordinary profit was ¥1,529 million, up 126.9%. Supported by strong demand in the buoyant real estate market, property sales in the brownfield redevelopment business progressed smoothly, and both sales and profit significantly exceeded the initial plan, resulting in higher sales and higher profit.」

    For the sales and profit metrics emphasized by the company, sales increased 31.0% and ordinary profit increased 126.9%, with both sales and profit significantly exceeding the initial plan.
  11. FY2023-Q1AdvancedAnnual report

    「Both sales and profit significantly exceeded the initial plan, resulting in higher sales and higher profit.」

    The company stated that, for the sales and profit metrics it emphasizes, cumulative first-quarter sales increased 38.9% year on year and ordinary profit increased 104.7%, significantly exceeding the initial plan.
  12. FY2022Specific numerical targetsAnnual report

    「Under the medium-term management plan through the fiscal year ending March 2025, the company set consolidated net sales of ¥14,145 million, operating profit of ¥1,107 million and ordinary profit of ¥761 million as performance targets for the fiscal year ending March 2025.」

    Specific performance targets were set for fiscal year ending March 2025 for net sales, operating profit and ordinary profit.
  13. FY2022-Q3AdvancedAnnual report

    「As a result, net sales for the cumulative third quarter of the current consolidated fiscal year were ¥7,341 million, up 33.7% year on year. Ordinary profit was ¥1,056 million, up 116.4%. In addition to higher sales, the main factor behind the increase in profit was the success of initiatives to improve the cost ratio in the soil contamination remediation business.」

    For the sales and profit metrics emphasized by the company, cumulative third-quarter sales increased 33.7% and ordinary profit increased 116.4%, while cost-ratio improvements also contributed to higher profit.
  14. FY2022-Q2AdvancedAnnual report

    「As a result, net sales for the first six months of the current consolidated fiscal year were ¥4,301,517 thousand, up 18.8% year on year. In terms of profitability, ordinary profit rose to ¥674,052 thousand, up 76.1%, and quarterly net income attributable to owners of the parent rose to ¥375,540 thousand, up 42.3%, owing to the effect of higher net sales in the brownfield utilization business and the effect of promoting proposals for high-margin projects addressing market needs in the soil contamination remediation business.」

    For the sales and profit metrics emphasized in the medium-term management plan, cumulative second-quarter sales increased 18.8% and ordinary profit increased 76.1%.
  15. FY2022-Q1Lower revenue and higher ordinary incomeAnnual report

    「As a result, net sales for the cumulative first quarter of the current consolidated fiscal year were ¥1,921 million, down 19.0% year on year. Ordinary profit was ¥396 million, up 2.2%.」

    In the first-quarter results after withdrawing the published figures for the medium-term management plan, the key sales figure declined, while ordinary profit increased year on year.
  16. FY2021SoftenedAnnual report

    「The published targets in Medium-Term Management Plan 2023, which were management objectives, have been temporarily withdrawn. Once the spread of COVID-19 has subsided, we plan to formulate a new plan and publish it again.」

    Although the company has maintained its focus on revenue, operating income and ordinary income as key metrics, it has temporarily withdrawn the published figures in its medium-term management plan.
  17. FY2021-Q3Year-on-Year Decline in Net Sales and Ordinary ProfitAnnual report

    「As a result, revenue for the nine months ended 31 December was ¥5,491.252 million, down 4.5% year on year. Ordinary income was ¥488.104 million, down 18.3%.」

    Revenue and ordinary income, which are emphasized in the medium-term management plan, both declined year on year in the nine months ended 31 December.
  18. FY2021-Q2Year-on-Year Decline in Net Sales and Ordinary ProfitAnnual report

    「As a result, revenue for the six months ended 30 September was ¥3,621.354 million, down 15.5% year on year. Ordinary income was ¥382.792 million, down 26.2%.」

    Revenue and ordinary income, which are emphasized in the medium-term management plan, both declined year on year in the six months ended 30 September.
  19. FY2021-Q1AdvancedAnnual report

    「As a result, revenue for the three months ended 30 June was ¥2,371.449 million, up 10.1% year on year. Ordinary income was ¥387.492 million, up 37.0%.」

    Revenue and ordinary income, which are emphasized in the medium-term management plan, both increased year on year in the three months ended 30 June.
  20. FY2020-Q3Declining revenue and improving profitAnnual report

    「As a result, revenue for the nine months ended 31 December was ¥5,747.205 million, down 11.9% year on year. Ordinary income was ¥597.370 million, up 80.4%.」

    While revenue, one of the key metrics, declined, ordinary income increased 80.4% year on year.
  21. FY2020-Q2AdvancedAnnual report

    「As a result, revenue for the six months ended 30 September was ¥4,287.952 million, up 7.2% year on year. Ordinary income was ¥518.854 million, up 299.3%.」

    Revenue and ordinary income, which are emphasized in the medium-term management plan, increased year on year in the six months ended 30 September, indicating progress in the key metrics.
  22. FY2019First statedAnnual report

    「As management metrics, we have identified revenue growth as important from the perspective of securing stronger growth, and operating income and ordinary income as important from the perspective of continuing to improve growth. We aim to continuously increase corporate value by expanding our operating base.」

    In the medium-term management plan ending in the fiscal year ending March 2023, the company identified revenue growth, operating income, ordinary income and expansion of its operating base as key metrics and strategic priorities.
Moved together

"Expansion of Renewable Energy Business" moved the same way as this thread, in the same document, in 9 of its 22 moves.

987755★123456
  1. ★This thread
  2. 1Expansion of Renewable Energy Business9×
  3. 2Improving the ratio of prime-contract orders and reducing the cost ratio through greater management efficiency8×
  4. 3Acquisition, remediation and resale or leasing of contaminated land7×
  5. 4Maintaining Stable Liquidity and Funding Sources Required for Business Operations7×
  6. 5Technology Development for Newly Regulated and Difficult-to-Treat Substances5×
  7. 6Increase in consolidated net sales and return to profitability5×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for EnBio Holdings,Inc yet. It last moved in the Management plan of 2026-05-15: "Raised".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Medium-Term Management Indicators Focusing on Revenue, Operating Profit and Ordinary Profit | EnBio Holdings,Inc (6092) | Komori